The series is stated in the current share scale after splits; dividends are not included in the price
Hims & Hers Health, Inc. (HIMS) is a public company in the healthcare sector. Its common stock trade on NYSE.
Over the trailing twelve months as reported to 2026-06-30, revenue was 2.6bn $, net income was -142.0m $. Incorporated in US.
This summary is compiled automatically from SEC filings and exchange data.
Based on the last 12 months of reports, through 30 June 2026
The sector median covers every company in the sector on the US market, loss-making ones included.
Share count is a period average, so market cap is approximate.
Hims & Hers Health, Inc. (HIMS) is a company in the Health care sector; its shares trade on NYSE.
The price of Hims & Hers Health, Inc. (HIMS) on November 2, 2026 is 25.70 $, −7.17 % on the day. Over 52 weeks the stock traded between 13.74 $ and 65.30 $; the price now sits 23 % of the way up that range. Over the past year the price changed by −53.19 %. Market capitalization is 6.25 billion $, rank 1 among 7 stocks of the same industry with a known capitalization.
Hims & Hers Health, Inc. trades on NYSE under the ticker HIMS. The company belongs to the Health care sector. The trading history on this page starts on 13 September 2019.
Over the past 52 weeks HIMS has traded between 13.74 $ and 65.30 $. As of 2 November 2026 the price stood 30.33 % of the way from the 52-week low to the high.
Over one year HIMS shares fell 53.19 %; over six months they rose 8.86 %. Volatility over 90 days is 84.02 %. Dividends are not included: this is price change only, as of 2 November 2026.
The company reported a loss over the last four quarters, so a price-to-earnings ratio is not calculated. Price to sales is 2.4, below the sector median of 3.6. Price to book is 19.3, above the sector median of 2.5. Calculated from reports for the period ending 30 June 2026.
Hims & Hers Health, Inc. reported revenue of 2.6B $ and a net loss of 142M $ over the last four quarters. Net margin is −5.51 %. Revenue changed by +28.04 % year over year. Earnings per share are −0.64 $. Market capitalisation is 6.3B $.
HIMS has a return on equity of −43.83 %, below the sector median of −40.58 %. Return on assets is −3.91 %, above the sector median of −30.08 %. Operating margin is −5.99 %, above the sector median of −20.96 %.
